Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Milles Medicinska AB
AB
Active
Org 5592909013
Nygatan 51
General medical practice activities · NACE 8621
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 1,4M
-45% vs 2023
EBITDA margin
48.0%
-57% vs 2023
Equity ratio
77.0%
Financial strength
Net profit 2024
SEK 515K
-58% vs 2023
EBITDA — year on year
SEK millions
3M
2M
1M
1M
0M
1M
2021
1M
0%
2022
2M
+100%
2023
1M
-50%
2024
Key figures
Annual report 2024
Revenue
SEK 1,4M
-45%
EBITDA
SEK 663K
-57%
Net profit
SEK 515K
-58%
Total assets
SEK 4,1M
+1%
Equity
SEK 3,1M
+20%
Employees
0
—
Company information
Legal name
Milles Medicinska AB
Org number
5592909013
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 december 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsult inom hälso- och sjukvård.
Contact
Address
Nygatan 51
Email
gorsaj@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Norrköping
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
3M
2M
2021
2M
2022
3M
2023
1M
2024
EBITDA
SEK millions
0M
1M
1M
2M
2M
1M
2021
1M
2022
2M
2023
1M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
2 111
2 274
2 507
1 381
Staff expenses
—
−754
−920
−690
EBITDA
1 479
1 474
1 536
663
Depreciation & amort.
−0
—
—
—
EBIT
1 479
1 474
1 536
663
Net financials
−1
−0
−3
−7
Profit before tax
1 110
1 109
1 534
656
Tax
−238
−229
−320
−141
Net profit
872
880
1 214
515
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
2 014
3 390
4 010
4 067
Equity
897
1 777
2 616
3 131
Long-term debt
0
—
—
—
Short-term debt
748
879
660
202
Total debt
748
879
660
202
Financial ratios
5-year trend
EBITDA margin
48.0%
This company
15.8%
Market median
+204% vs market
2021
2024
Equity ratio
77.0%
This company
38.2%
Market median
+102% vs market
2021
2024
Return on equity
16.4%
This company
18.4%
Market median
+11% vs market
2021
2024
Net profit margin
37.3%
This company
8.1%
Market median
+360% vs market
2021
2024
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
2021
2024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
DS
Dejan Sajinovic
Deputy Board Member
2022
GS
Goran Sajinovic
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Milles Medicinska AB also hold positions in
0
other companies.
Person
Role here
Other companies
Dejan Sajinovic
Deputy Board Member
0 companies
Goran Sajinovic
Board of Directors
0 companies